SCHEMBL30846168

SCHEMBL30846168

Cn1ccc2cccc(NS(=O)(=O)c3ccc(Cl)nc3)c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.55
▸ LMNA P02545 2/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ CCR2 P41597 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ SLC40A1 Q9NP59 8/20 0.43
▸ PTPN11 Q06124 1/20 0.41
▸ SCN9A Q15858 1/20 0.41
▸ MITF O75030 1/20 0.40
▸ S1PR4 O95977 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ S1PR1 P21453 1/20 0.40
▸ AGTR1 P30556 1/20 0.40
▸ OPRK1 P41145 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ CKS1B P61024 1/20 0.40
▸ SKP2 Q13309 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27125947 1.00 GAA (0.55) GAALMNAMAPK1CCR2ALDH1A1
SCHEMBL27123592 0.83 GAA (0.55) GAALMNAMAPK1CCR2ALDH1A1
SCHEMBL30846193 0.83 GAA (0.55) GAALMNAMAPK1CCR2ALDH1A1
SCHEMBL27125948 0.83 TDP1 (0.41) GAALMNAMAPK1ALDH1A1KMT2A
SCHEMBL3600251 0.80 LMNA (0.54) LMNAALDH1A1KMT2AMEN1SLC40A1
SCHEMBL27119245 0.77 GAA (0.48) GAALMNAMAPK1CCR2ALDH1A1
SCHEMBL27123808 0.76 LMNA (0.50) GAALMNAMAPK1CCR2ALDH1A1
SCHEMBL30846236 0.76 LMNA (0.50) GAALMNAMAPK1CCR2ALDH1A1
SCHEMBL30846442 0.76 SLC40A1 (0.41) LMNAMAPK1SLC40A1PTPN11SCN9A
SCHEMBL27125949 0.76 SLC40A1 (0.41) LMNAMAPK1SLC40A1PTPN11SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024044344-A1 PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback